LeafCann is a botanical extracts company, who has recently opened a new warehouse in South Australia. The warehouse will house medical cannabis products and be as a distribution hub for overseas products.
Cannabis flower medicines are turning out to be popular with Australian doctors, due to its fast pain controlling abilities. The new flower range from Little Green Pharma is a Schedule 8 medicine, which will be prescribed by a doctor.
As the demands for medicinal cannabis medications in Australia rise, patients are worried they will not be able to get enough medication to treat their ailments, with some having to ration their does to get by.
Australian cannabis company Cronos (ASX: CAU) will be set to start stacking Asian shelves with a pure cannabidiol (CBD) heat and cooling gel for elite athletes to help with recovery. The gels for Australian’s, however, may take some time.
A German study which has researched how cannabis is used for treatment in a medical setting has advised that rules and clear guidelines need to be set out, to create a legal framework that fully states the facts.
Prof. Raphael Mechoulam was the first scientist to isolate and synthesize the active psychoactive components in cannabis. Today, he has more plans to develop medical cannabis treatments using cannabis acids.
Dr Andrew Agius, Medical Director at the Pain Clinic, speaks about the benefits of using cannabis to treat chronic pain, and the areas where additional research on the matter needs to be performed.
Researchers from the Department of Neuroscience at the Faculty of Health and Medical Sciences have found new information related to the medicinal use of cannabis for certain medical treatments, which could prove essential.
Taking advantage of the huge, and ever-growing cannabis medical market, CSIRO is looking to partner with local manufacturers to produce medical cannabis products, such as tablets and cough lollies.
Tasmanian GP’s will be able to approve patients for medicinal cannabis prescriptions from July 2021. However, access to these drugs may still be a longer and hard process, leaving patients waiting.
Epsilon Healthcare’s (EPN) Telehealth medical cannabis clinic group Tetra Health has opened its first physical clinic in Victoria, Australia. Tetra will be the preferred medical cannabis supplier and partner for in-house consultations.
The Commonwealth Scientific and Industrial Research Organisation (CSIRO) has been granted a licence to partner with local manufacturers to make medical cannabis products. The partnership is said to produce more jobs for Australians.
A huge plot of over 45 Hectares, more than 800 kilometres north of Perth, in the Gascoyne region, has been approved to be one of the largest in the Southern Hemisphere and is deemed for success.
A 10-year deal reached between the Australian Natural Therapeutics Group (ANTG) and the EU could mean that Australia is set to be a leader in the medical cannabis industry, after a major shipment to the European Union.
There is a debate in Western Australia over whether it should ease the rules surrounding the use of THC in medical cannabis prescriptions, which would fall in line with the rest of Australia’s states.
A research study by Applied Cannabis Research has found that using cannabis as a medical treatment, could help with patients suffering from chronic pain. This could help the 1 in 5 Australians who currently cope with long-term pain.
The Therapeutic Goods Administration (TGA) has announced it will remove limitations for buying cannabidiol (CBD) in Australia. This means that people aged over the age of 18 will now be able to buy low-dose medicinal cannabis without a prescription.
An Australia-led study has found that using cannabidiol (CBD) is safe for drivers and does not impair driving ability. Lead author of the Journal of the American Medical Association says this is good news for CBD-based products.
The Cannabinoid Medicine Observational Study (CMOS) intends to collect data from 20,000 patients across the country. The study will observe how patients with a variety of illness and conditions react to medicinal cannabis.
The Therapeutic Goods Administration (TGA) could make cannabidiol (CBD) medicine available from next year, without needing a prescription. This medication would benefit around 2.4 million people.
Even though the production of cannabis in Tasmania is good, patients are finding it hard to access medications, and therefore turning to the black market or growing their own to help with medical issues.
Tasmanian Alkaloids’ have opened up a new medicinal cannabis facility in the central-north region of Tasmania. It will cultivate, extract, and create medical cannabis medications, with up to 90 tonnes each year.
Tasmania’s Controlled Access Scheme has only approved 36 applications for medicinal cannabis prescriptions, compared to 56,000 applications on the mainland.
Insight in how research companies undertake research and development conduct dosing studies and clinical trials. Why are dosing studies important and what research has already been completed in Australia on cannabis trials.
Unlike the majority of cannabis cultivation sites, an undisclosed location in Victoria is now growing cannabis naturally on an outdoor site. This could help provide affordable medicine for those in desperate need.
A guide to what CBD oils actually is, what it can help with and how you are get it within Australia. As CBD oil becomes more mainstream, should you be concerned about using it?
Cannabis in a tablet form has arrived in Australia. Queensland medicinal cannabis wafers are becoming available to certain patients. Read about the benefits of this technology.
Ex drug cop Max Hill, father of David, describes how he helped his son through post-traumatic stress disorder and even turned to the black market to help his son find the medical cannabis he needed. David also describes his experience.
Does allowing easier and cheaper access to medical cannabis reduce the harm? Dr Orit Holtzman, a doctor from New South Wales, thinks it does. Here is what she has to say.
Patients speak about how the Federal Government regulates medicinal cannabis has made it excessively expensive, costing some up to $600 a month. Patients are finding other ways to get their hands on the drug, including the black market.
